Adcetris Injection, Powder, Lyophilized, For Solution
Product Images NDC 51144-050

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Adcetris (NDC 51144-050). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Seagen Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cartonlabel

Cartonlabel
This is a drug information label for the drug 'brentuximab vedotin'. It is a 50mg/vial single-dose injection for intravenous use only. The label provides directions for reconstitution and dilution of the drug and includes recommended dosage and storage information. The label also includes the drug's manufacturer, Seagen, and contact information for more information.*
FDA Label Image

Carton Label (Label)

Carton Label (Label)
This is a description for B-Rentuximab Vedotin, an injectable drug with a strength of 50mg/vial, intended for intravenous use only. The drug is stored in a single-dose vial and requires reconstitution and dilution before administration. It is recommended to store the vial at 2°C to 8°C to protect it from light. The drug is manufactured by Seagen Inc., and its prescribing information contains details about dosage and dilution. The given text also includes the drug's NDC code, recommended storage, and manufacturer's license number. No further description is available.*
FDA Label Image

Figure 1 (Figure1)

FDA Label Image

Figure 2 (Figure2)

FDA Label Image

Figure 3 (Figure3)

Figure 3 (Figure3)
The text is a graph showing the Progression-Free Survival measured by the Kaplan Meier Curve of IRF-Assessed Progression-Free Survival from Study 6: ECHELON-2. The graph is comparing the ACHP group versus the CHOP group. The x-axis indicates the time from randomization in months, and the y-axis indicates the natural risk events. There are numbers and letters scattered throughout the graph, representing each group's details and results.*
FDA Label Image

Figure4

FDA Label Image

Figure5

FDA Label Image
FDA Label Image

Structural Formula (Structuralformula)

FDA Label Image

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.